In children aged 5 to 15 years with mild asthma, budesonide-formoterol reliever monotherapy is superior to salbutamol for ...

Inhaler Reduces Asthma Attacks by 45% The results show that using a single 2-in-1 anti-inflammatory reliever inhaler – which ...

Commercial rights cover Greater China with first launch slated Q2 2026, handing pharma blogs CXG87 keywords and revenue ...

Changxi Pharma & Huadong Medicine enter commercialization collaboration on the improved respiratory system drug CXG87: Hangzhou, China Friday, October 10, 2025, 11:00 Hrs [IST] Ha ...

Chance Pharmaceuticals ("Chance" or "Chance Pharma"), a clinical-stage biotechnology company dedicated to the research and ...

There are different kinds of asthma, like nocturnal asthma, allergic asthma, and occupational asthma. Here's what causes and ...

Common metered-dose inhalers, used by many for respiratory issues, are contributing significantly to greenhouse gas emissions ...

A new study found that a 2-in-1 anti-inflammatory inhaler reduced asthma attacks in children by 45% compared to the ...

Metered-dose inhaler propellants have contributed a rising amount to greenhouse gases in the U.S. Emissions per inhaler ...

Adding home remedies on top of your prescribed asthma medications can help you fight inflammation and remove stale air from ...

AstraZeneca Plc said on Thursday its asthma treatment for a chronic inflammatory disease of the nasal passage linings, or sinuses, met main goals in a late-stage study.

"These emissions drive global warming, exacerbating the very respiratory conditions inhalers are meant to relieve," ...